Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction

2012 ◽  
Vol 14 (8) ◽  
pp. 902-908 ◽  
Author(s):  
Eustachio Agricola ◽  
Stefano Stella ◽  
Mariangela Gullace ◽  
Giacomo Ingallina ◽  
Rossella D'Amato ◽  
...  
Author(s):  
Bo Gao ◽  
Zhaoming He

Functional mitral regurgitation, which occurs as a consequence of regional of global left ventricular or global left ventricular dysfunction despite structurally normal mitral valve (MV), is a common complication in patients with ischemic or non-ischemic cardiomyopathies [1].


2019 ◽  
Vol 13 (1) ◽  
pp. 30-34
Author(s):  
Mehmet Ali Elbey ◽  
Luis Augusto Palma Dallan ◽  
Guilherme Ferragut Attizzani ◽  

Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality. Percutaneous mitral valve repair using the MitraClip (Abbott) has been shown to be safe and effective in secondary severe mitral regurgitation with heart failure. The number of MitraClip procedures performed has increased significantly, as recently published large, randomized clinical studies have shown. However, these studies have drawn different conclusions. This review aims to summarize the current evidence for the MitraClip procedure and provide information for its safe and successful implementation, comparing the studies that examined the use of MitraClip versus medical therapy alone or surgical repair for severe secondary mitral regurgitation.


Circulation ◽  
2000 ◽  
Vol 102 (12) ◽  
pp. 1400-1406 ◽  
Author(s):  
Siu F. Yiu ◽  
Maurice Enriquez-Sarano ◽  
Christophe Tribouilloy ◽  
James B. Seward ◽  
A. Jamil Tajik

Sign in / Sign up

Export Citation Format

Share Document